Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004080436 | SCV003544567 | uncertain significance | not specified | 2022-11-08 | criteria provided, single submitter | clinical testing | The c.199C>T (p.R67W) alteration is located in exon 3 (coding exon 3) of the CTU2 gene. This alteration results from a C to T substitution at nucleotide position 199, causing the arginine (R) at amino acid position 67 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Gene |
RCV004798024 | SCV005419791 | uncertain significance | not provided | 2024-05-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005021673 | SCV005646335 | likely pathogenic | Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome | 2024-03-21 | criteria provided, single submitter | clinical testing |